Comparative Analysis of Trichoscopic Features in Women with Androgenetic Alopecia and Telogen Effluvium
Journal of Basic and Clinical Health Sciences · 31.05.2026 · 10 (2) · 167-173
DOI: 10.30621/jbachs.1677821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Clinical Health Sciences, online erschienen am 31.05.2026. Verfasst von Isil Kamberoglu Turan und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Purpose
Female androgenetic alopecia (FAGA) and telogen effluvium (TE) are two of the most common causes of hair loss in women. Due to the considerable overlap in their clinical features, accurate differentiation is essential for appropriate treatment planning. Material and Methods: This cross-sectional study included 110 female patients clinically diagnosed with FAGA or TE at the Department of Dermatology, XXX University. Trichoscopic images of the frontal and occipital scalp regions were obtained at 40× magnification. The presence of predefined trichoscopic features was assessed by two blinded dermatologists.
Results
Trichoscopic findings associated with FAGA included hair diameter diversity (p
Förderung
- None
Zitieren
APA
Turan, I. K., & Özbağcivan, Ö. (2026). Comparative Analysis of Trichoscopic Features in Women with Androgenetic Alopecia and Telogen Effluvium. Journal of Basic and Clinical Health Sciences, 10(2), 167-173. https://doi.org/10.30621/jbachs.1677821
Vancouver
Turan IK, Özbağcivan Ö. Comparative Analysis of Trichoscopic Features in Women with Androgenetic Alopecia and Telogen Effluvium. Journal of Basic and Clinical Health Sciences. 2026;10(2):167-173. doi:10.30621/jbachs.1677821
BibTeX
@article{Turan2026,
author = {Turan, Isil Kamberoglu and Özbağcivan, Özlem},
title = {Comparative Analysis of Trichoscopic Features in Women with Androgenetic Alopecia and Telogen Effluvium},
journal = {Journal of Basic and Clinical Health Sciences},
year = {2026},
volume = {10},
number = {2},
pages = {167--173},
doi = {10.30621/jbachs.1677821}
}
EUVIMED